Ursula Wiedermann

Medical University of Vienna

Austria

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

100%

Virology

80%

Immune Response

30%

Vaccinology

30%

Sars-cov-2

30%

Adjuvant Therapy

30%

Vaccine Development

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles12

Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants

Article Link

Year:

2024

Lack of seroprotection against diphtheria in the Austrian population, in light of reported diphtheria cases in Europe, 2022

Article Link

Year:

2023

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial

Article Link

Year:

2022

NKG2A‐checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA‐E

Article Link

Year:

2022

SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 Year

Article Link

Year:

2022

Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer

Article Link

Year:

2022

A Rapid FRET Real-Time PCR Protocol for Simultaneous Quantitative Detection and Discrimination of Human Plasmodium Parasites

Article Link

Year:

2022

Active immunization with a Her-2/neu-targeting Multi-peptide B cell vaccine prevents lung metastases formation from Her-2/neu breast cancer in a mouse model

Article Link

Year:

2022

Autochthonous Human Dirofilaria repens Infection in Austria

Article Link

Year:

2022

Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases

Article Link

Year:

2022

Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule.

Article Link

Year:

2022

SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease

Article Link

Year:

2022

Collaborators7

Venugopal Gudipati

Medical University of Vienna

AUSTRIA

Peter Steinberger

Medical University of Vienna

AUSTRIA

Anna Sophie Berghoff

Medical University of Vienna

AUSTRIA

Winfried F. Pickl

AUSTRIA

Johannes Huppa

Professor

Medical University of Vienna

AUSTRIA

Daniel Mrak

Medical University of Vienna

AUSTRIA

Michael Bonelli

Medical University of Vienna

AUSTRIA

How do I reach out?

Meet Kite AI